HEALTH● LOWAug 13 · Aug 13, 2026, 11:17 PM
Capricor outlines BLA amendment plan as FDA signals willingness to review, with PDUFA date set for August 22
Seeking Alpha Tech
Capricor is preparing a Biologics License Application amendment, with the FDA indicating its willingness to review it and a PDUFA date set for August 22. This signifies progress in the company's drug approval process.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH9m agoProud Kakinada is at the heart of India’s return to making Penicillin, says Andhra HRD Minister Nara LokeshThe HinduHEALTH13m agoKeralam to adopt calendar-based infectious disease prevention strategyThe HinduHEALTH24m agoItaly first in Europe to establish national plan against fentanyl says MeloniANSA [en]HEALTH27m agoMalaria: Nigeria’s prevalence drops to 15.2%, FG targets 50% reduction by 2030Vanguard Nigeria